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e would like to thank Dr. Movahed for his interest in our paper (1),
nd welcome the opportunity to respond to his comments.
We agree that echocardiography is a valuable tool in the evaluation of
atients who present with signs and symptoms suggestive of an acute
oronary syndrome, a situation in which takotsubo cardiomyopathy is an
mportant differential diagnosis.We also agree that there are several clinical
nd echocardiographic characteristics that are highly suggestive of the
iagnosis of takotsubo cardiomyopathy. There are specific situationswhere
he presentation is compelling enough that coronary angiography may be
easonably deferred in the presence of significant comorbidities that would
ncrease the risk of cardiac catheterization. However, the pattern of
egional wallmotion abnormality of the left ventricle inmany patientswith
n acute coronary syndrome, especially when due to ischemia in the left
nterior descending coronary artery territory, can mimic takotsubo cardio-
yopathy. Moreover, in occasional patients with takotsubo cardiomyop-
thy, the pattern of regional wall motion abnormality may not involve
ultiple coronary distributions. Thus, given the typically low risk of
erforming coronary angiography in most patients and the potential
dverse consequences of an incorrect diagnosis with respect to an acute
oronary syndrome, we advocate that urgent or emergent coronary
ngiography be performed in the absence of absolute contraindications, to
xclude occlusive coronary artery disease. Indeed, takotsubo cardiomyop-
thy can, in rare circumstances, coexist with occlusive coronary artery
isease, as highlighted in the modifiedMayo Clinic diagnostic criteria (2).
ltimately, clinical judgment is required to differentiate takotsubo cardio-
yopathy from other etiologies of acute coronary syndrome.
. Todd Hurst, MD,* Abhiram Prasad, MD, J. Wells Askew III,
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morphology. J Am Coll Cardiol Img 2010;3:641–9.
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adiation Exposure From Cardiac
omputed Tomography
e read with interest the article by Ho et al. (1) in the recent edition
f iJACC. Computed tomography (CT) myocardial perfusion imaging
MPI) offers a new, noninvasive functional assessment of myocardial
schemia. When combined with CT coronary angiography, it may
ffer the strong negative predictive value of an anatomical test and the
pecificity of functional testing in a “1-stop shop.”
CT MPI accuracy and radiation dose has been compared with
uclear MPI as a reference.
The effective radiation dose from a medical exposure is measured in
Sv. This value takes into account the different radiation sources and
he potential biological harm from exposure to a particular organ.
issues with a high susceptibility to harm from ionizing radiation are
llocated a higher weighting in the calculation of effective dose—a
igher tissue weighting factor. In 2007, the International Commission
n Radiological Protection (ICRP) updated the tissue weighting
actors in light of further epidemiological studies; of importance is the
ncrease in the breast-tissue weighting factor from 0.05 to 0.12 (2).
There is now increasing evidence that previously published chest
onversion factors (when applied to cardiac CT) significantly under-
stimate the effective dose to the patient. This is due to 2 factors: 1) the
hange in the ICRP tissue weighting factors mentioned earlier; and 2)
he marked difference in scan volume between cardiac and whole-chest
T scans. Cardiac CT scans only irradiate the lower chest and upper
bdomen, a scan field that involves irradiating the breast tissue for the
ajority of the scan volume, rather than including the relatively
adio-insensitive tissues of the upper chest.
Work in our institution (3) using computer-based anthropomor-
hic phantoms has demonstrated that the conversion factor for
ardiac CT is at least double that previously reported; this has been
onfirmed by other groups (4–6).
We suggest a conversion factor of 0.028 (3) for prospectively gated
ardiac CT—which would result in a doubling of the reported dose to
6.5 mSv for the stress and rest examination in the paper by Ho et al.
1). With increasing evidence of the risk of ionizing radiation from
edical exposure (7), further dose reduction strategies will be needed
efore CT MPI becomes the primary choice for functional imaging
ver established techniques such as stress echocardiography and cardiac
agnetic resonance.
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e thank Gosling and Roobottom for their interest in our paper (1),
nd we agree that, following the ALARA (as low as reasonably
chievable) principle, further research in computed tomography (CT)
yocardial perfusion imaging (MPI) should include efforts at dose
eduction. We are aware of the growing number of studies refining the
alculation of effective dose, but we do not agree that as a consequence
f recalculated conversion factors, “further dose reduction strategies
ill be needed before CT MPI becomes the primary choice for
unctional imaging.”
This conclusion is based on the implicit assumption that the risk
ssociated with CT MPI as reported by us is twice as high as in
ingle-photon emission computed tomography (SPECT), and that this
ifference is significant. As carefully detailed in Martin’s (2) review of the
se of effective dose, the estimated risk of cancermay be a factor of 3 higher
r lower when applied to a reference patient.Martin (2) therefore suggests
escribing risk using broad categories spanning a factor of 10 in effective
ose. McCollough et al. (3) in a recent review paper share this interpre-
ation. They conclude that “effective dose should not be used for epide-
iologic studies or for estimating population risks,” and they state that
with such uncertainties, it is clear that the current emphasis on calculating
nd reporting effective dose is not merited.”
Even if one were to approximately assess risk based on effective dose
alculations, a little more refinement might be necessary in calculating
he conversion factors. In comparison to coronary computed tomog-
aphy angiography (CTA), significantly less breast tissue is exposed in
T MPI with a scan range of less than 8 cm above the diaphragm.oreover, Deak et al. (4) in a very recent paper strongly advocate sex-
nd age-specific conversion factors. They suggest significantly higher
hest conversion factors for the average adult reference woman, but
heir factor for adult men is actually lower than the one we used. Last,
atients undergoing stress perfusion imaging tend to be those at higher
isk of coronary artery disease, i.e., older, and post-menopausal if
emale. For women, the risk factor for breast exposure decreases by a
actor of 2 to 3 between ages 30 and 50 (5).
If one would correct the organ weighting factor for the fraction
f breast tissue actually exposed to radiation during CT MPI, and
se age- and sex-specific conversion factors that reflect the demo-
raphics of perfusion imaging patients, then there might be little
ifference in “procedure effective dose” from what was calculated
ith the original conversion factor.
This, however, was not the scope of our paper (1). Our study evaluated
he feasibility of CT MPI and validated it in comparison with nuclear
PI. We did not assess the exact utility of CT MPI as part of a
omprehensive cardiac CT examination. For instance, as discussed by
urselves and others (6), dynamic CTMPI at rest might be replaced with
arenchymal information obtained during the coronary CTA study. Such
rotocols would directly halve the dose.
Considering all these factors, we believe that the conclusion of
ur paper, that CT MPI provides comparable diagnostic informa-
ion to SPECT at comparable dose levels, is justified.
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